The medical device market in Hong Kong reached about $850 million in 2012, and it is expected to grow at an annual rate of 8.5 percent for the next five years. This is a good sized market, considering Hong Kong's small population... Read More
Cardiovascular disease is common in Asia, where it is a leading cause of death in countries from Japan to India to China. Of the 17.3 million deaths caused by cardiovascular disease each year, nearly 60 percent occur in Asia, according to the... Read More
Taiwan might be an economic lightweight compared to its mainland cousin, but in the medical device market, the island nation of 23.3 million makes up for its small size. It has a medical device market of $2.5 billion, the fifth-largest in Asia.... Read More
The country of South Korea is one of the world's leading economies -- the 15th largest by GDP in 2012, and the fourth largest in Asia. In 2011, the Korean medical device market had a value of $3.9 billion, according to the... Read More
Thailand's medical device market was worth more than $850 million in 2012 and is set to expand at 7.5 percent annually over the next several years. The medical device market in Thailand continues to boast strong economic growth, even in the face... Read More
The medical device market in Singapore reached $535 million last year, despite its small land area and a population of only 4.7 million. Singaporeans' strong demand for better healthcare creates an excellent market for foreign medical device companies, who supply more than... Read More
The medical device market in India grew to $3 billion by the end of 2011. According to a recent report, that figure should more than triple over the next ten years, to reach $10 billion by 2022. While India's market grows at... Read More
Beginning January of 2013, the Taiwanese Food and Drug Administration (TFDA) will begin trial of the Essential Principles (EP) and Summary of Technical Documentation (STED) format for class III devices, with mandatory EP/STED required for all 2014 submissions. The move is part... Read More
In line with recommendations from the Global Harmonization Task Force, the Singapore Health Sciences Authority (HSA) has implemented two new evaluation routes for Class C and Class D medical devices in Singapore as of January 1, 2013. Previous Routes: Full Evaluation Route:... Read More
In June 2012, Taiwan’s Department of Health (DOH) announced that it would allow the sales of low-risk Class I medical devices through “virtual channels” starting July 2012. Virtual channels are any instances in which the medical device cannot be examined by customers... Read More